1. Home
  2. DTIL vs AMWL Comparison

DTIL vs AMWL Comparison

Compare DTIL & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$4.32

Market Cap

97.7M

Sector

Health Care

ML Signal

HOLD

AMWL

American Well Corporation

HOLD

Current Price

$5.36

Market Cap

89.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTIL
AMWL
Founded
2006
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
97.7M
89.9M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
DTIL
AMWL
Price
$4.32
$5.36
Analyst Decision
Strong Buy
Hold
Analyst Count
1
7
Target Price
$60.00
$7.42
AVG Volume (30 Days)
154.1K
144.1K
Earning Date
03-31-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
106.52
57.06
EPS
N/A
N/A
Revenue
$1,070,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$34.30
$4.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.53
$3.71
52 Week High
$8.82
$9.15

Technical Indicators

Market Signals
Indicator
DTIL
AMWL
Relative Strength Index (RSI) 59.29 54.29
Support Level $4.17 $4.48
Resistance Level $4.61 $5.74
Average True Range (ATR) 0.25 0.45
MACD 0.06 0.04
Stochastic Oscillator 94.34 63.28

Price Performance

Historical Comparison
DTIL
AMWL

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

Share on Social Networks: